Cover Image
Market Research Report

Global Influenza Therapeutics Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 913433
Published Content info 90 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Influenza Therapeutics Market Size, Status and Forecast 2019-2025
Published: October 8, 2019 Content info: 90 Pages
Description

Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.

In 2018, the global Influenza Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

  • Abbott Laboratories
  • Astrazeneca PLC
  • Biocryst Pharmaceuticals, Inc.
  • Chiron Corporation
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline PLC
  • Mitsubishi Tanabe Pharma Corporation
  • Nanotherapeutics Inc.
  • Protein Sciences Corporation
  • Roche Holding AG
  • Sanofi SA
  • Shionogi & Co., Ltd.
  • Sinovac Biotech Ltd.

Market segment by Type, the product can be split into

  • Vaccines
  • Drugs

Market segment by Application, split into

  • Hospitals
  • Clinic
  • Others

Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players.
  • To present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Influenza Therapeutics are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year: 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1. Report Overview

  • 1.1. Study Scope
  • 1.2. Key Market Segments
  • 1.3. Players Covered
  • 1.4. Market Analysis by Type
    • 1.4.1. Global Influenza Therapeutics Market Size Growth Rate by Type (2014-2025)
    • 1.4.2. Vaccines
    • 1.4.3. Drugs
  • 1.5. Market by Application
    • 1.5.1. Global Influenza Therapeutics Market Share by Application (2019-2025)
    • 1.5.2. Hospitals
    • 1.5.3. Clinic
    • 1.5.4. Others
  • 1.6. Study Objectives
  • 1.7. Years Considered

2. Global Growth Trends

  • 2.1. Influenza Therapeutics Market Size
  • 2.2. Influenza Therapeutics Growth Trends by Regions
    • 2.2.1. Influenza Therapeutics Market Size by Regions (2019-2025)
    • 2.2.2. Influenza Therapeutics Market Share by Regions (2014-2019)
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers
    • 2.3.3. Market Challenges
    • 2.3.4. Porter's Five Forces Analysis

3. Market Share by Key Players

  • 3.1. Influenza Therapeutics Market Size by by Players
    • 3.1.1. Global Influenza Therapeutics Revenue by by Players (2014-2019)
    • 3.1.2. Global Influenza Therapeutics Revenue Market Share by by Players (2014-2019)
    • 3.1.3. Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2. Influenza Therapeutics Key Players Head office and Area Served
  • 3.3. Key Players Influenza Therapeutics Product/Solution/Service
  • 3.4. Date of Enter into Influenza Therapeutics Market
  • 3.5. Mergers & Acquisitions, Expansion Plans

4. Breakdown Data by Type and Application

  • 4.1. Global Influenza Therapeutics Market Size by Type (2014-2019)
  • 4.2. Global Influenza Therapeutics Market Size by Application (2014-2019)

5. North America

  • 5.1. North America Influenza Therapeutics Market Size (2014-2019)
  • 5.2. Influenza Therapeutics Key Players in North America
  • 5.3. North America Influenza Therapeutics Market Size by Type
  • 5.4. North America Influenza Therapeutics Market Size by Application

6. Europe

  • 6.1. Europe Influenza Therapeutics Market Size (2014-2019)
  • 6.2. Influenza Therapeutics Key Players in Europe
  • 6.3. Europe Influenza Therapeutics Market Size by Type
  • 6.4. Europe Influenza Therapeutics Market Size by Application

7. China

  • 7.1. China Influenza Therapeutics Market Size (2014-2019)
  • 7.2. Influenza Therapeutics Key Players in China
  • 7.3. China Influenza Therapeutics Market Size by Type
  • 7.4. China Influenza Therapeutics Market Size by Application

8. Japan

  • 8.1. Japan Influenza Therapeutics Market Size (2014-2019)
  • 8.2. Influenza Therapeutics Key Players in Japan
  • 8.3. Japan Influenza Therapeutics Market Size by Type
  • 8.4. Japan Influenza Therapeutics Market Size by Application

9. Southeast Asia

  • 9.1. Southeast Asia Influenza Therapeutics Market Size (2014-2019)
  • 9.2. Influenza Therapeutics Key Players in Southeast Asia
  • 9.3. Southeast Asia Influenza Therapeutics Market Size by Type
  • 9.4. Southeast Asia Influenza Therapeutics Market Size by Application

10. India

  • 10.1. India Influenza Therapeutics Market Size (2014-2019)
  • 10.2. Influenza Therapeutics Key Players in India
  • 10.3. India Influenza Therapeutics Market Size by Type
  • 10.4. India Influenza Therapeutics Market Size by Application

11. Central & South America

  • 11.1. Central & South America Influenza Therapeutics Market Size (2014-2019)
  • 11.2. Influenza Therapeutics Key Players in Central & South America
  • 11.3. Central & South America Influenza Therapeutics Market Size by Type
  • 11.4. Central & South America Influenza Therapeutics Market Size by Application

12. International Players Profiles

  • 12.1. Abbott Laboratories
    • 12.1.1. Abbott Laboratories Company Details
    • 12.1.2. Company Description and Business Overview
    • 12.1.3. Influenza Therapeutics Introduction
    • 12.1.4. Abbott Laboratories Revenue in Influenza Therapeutics Business (2014-2019))
    • 12.1.5. Abbott Laboratories Recent Development
  • 12.2. Astrazeneca PLC
    • 12.2.1. Astrazeneca PLC Company Details
    • 12.2.2. Company Description and Business Overview
    • 12.2.3. Influenza Therapeutics Introduction
    • 12.2.4. Astrazeneca PLC Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.2.5. Astrazeneca PLC Recent Development
  • 12.3. Biocryst Pharmaceuticals, Inc.
    • 12.3.1. Biocryst Pharmaceuticals, Inc. Company Details
    • 12.3.2. Company Description and Business Overview
    • 12.3.3. Influenza Therapeutics Introduction
    • 12.3.4. Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.3.5. Biocryst Pharmaceuticals, Inc. Recent Development
  • 12.4. Chiron Corporation
    • 12.4.1. Chiron Corporation Company Details
    • 12.4.2. Company Description and Business Overview
    • 12.4.3. Influenza Therapeutics Introduction
    • 12.4.4. Chiron Corporation Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.4.5. Chiron Corporation Recent Development
  • 12.5. CSL Limited
    • 12.5.1. CSL Limited Company Details
    • 12.5.2. Company Description and Business Overview
    • 12.5.3. Influenza Therapeutics Introduction
    • 12.5.4. CSL Limited Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.5.5. CSL Limited Recent Development
  • 12.6. Daiichi Sankyo Co., Ltd.
    • 12.6.1. Daiichi Sankyo Co., Ltd. Company Details
    • 12.6.2. Company Description and Business Overview
    • 12.6.3. Influenza Therapeutics Introduction
    • 12.6.4. Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.6.5. Daiichi Sankyo Co., Ltd. Recent Development
  • 12.7. Glaxosmithkline PLC
    • 12.7.1. Glaxosmithkline PLC Company Details
    • 12.7.2. Company Description and Business Overview
    • 12.7.3. Influenza Therapeutics Introduction
    • 12.7.4. Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.7.5. Glaxosmithkline PLC Recent Development
  • 12.8. Mitsubishi Tanabe Pharma Corporation
    • 12.8.1. Mitsubishi Tanabe Pharma Corporation Company Details
    • 12.8.2. Company Description and Business Overview
    • 12.8.3. Influenza Therapeutics Introduction
    • 12.8.4. Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.8.5. Mitsubishi Tanabe Pharma Corporation Recent Development
  • 12.9. Nanotherapeutics Inc.
    • 12.9.1. Nanotherapeutics Inc. Company Details
    • 12.9.2. Company Description and Business Overview
    • 12.9.3. Influenza Therapeutics Introduction
    • 12.9.4. Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.9.5. Nanotherapeutics Inc. Recent Development
  • 12.10. Protein Sciences Corporation
    • 12.10.1. Protein Sciences Corporation Company Details
    • 12.10.2. Company Description and Business Overview
    • 12.10.3. Influenza Therapeutics Introduction
    • 12.10.4. Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2014-2019)
    • 12.10.5. Protein Sciences Corporation Recent Development
  • 12.11. Roche Holding AG
  • 12.12. Sanofi SA
  • 12.13. Shionogi & Co., Ltd.
  • 12.14. Sinovac Biotech Ltd.

13. Market Forecast 2019-2025

  • 13.1. Market Size Forecast by Product (2019-2025)
  • 13.2. Market Size Forecast by Application (2019-2025)
  • 13.3. Market Size Forecast by Regions
  • 13.4. North America
  • 13.5. Europe
  • 13.6. China
  • 13.7. Japan
  • 13.8. Southeast Asia
  • 13.9. India
  • 13.10. Central & South America

14. Analyst's Viewpoints/Conclusions

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 15.1.2.2. Primary Sources
  • 15.2. Disclaimer
  • 15.3. Author Details

List of Tables and Figures

  • Table Influenza Therapeutics Key Market Segments
  • Table Key Players Influenza Therapeutics Covered
  • Table Global Influenza Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
  • Figuer Vaccines Figures
  • Table Key Players of Vaccines
  • Figuer Drugs Figures
  • Table Key Players of Drugs
  • Table Global Influenza Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
  • Figure Global Influenza Therapeutics Market Share by Application in 2018 & 2025
  • Figure Hospitals Case Studies
  • Figure Clinic Case Studies
  • Figure Others Case Studies
  • Figure Influenza Therapeutics Report Years Considered
  • Figure Global Influenza Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Influenza Therapeutics Market Size by Regions 2019-2025 (Million US$)
  • Table Global Influenza Therapeutics Market Size by Regions 2019-2025 (Million US$)
  • Table Global Influenza Therapeutics Market Share by Regions 2014-2019
  • Figure Global Influenza Therapeutics Market Share by Regions 2014-2019
  • Figure Global Influenza Therapeutics Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Key Drivers: Impact Analysis (2019-2025)
  • Table Key Challenges
  • Figure PORTER'S FIVE FORCES ANALYSIS
  • Table Global Influenza Therapeutics Revenue by by Players (2014-2019) (Million US$)
  • Table Global Influenza Therapeutics Market Share by by Players (2014-2019)
  • Figure Global Influenza Therapeutics Market Share by by Players in 2018
  • Table Global Influenza Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Influenza Therapeutics Product/Solution/Service
  • Table Date of Enter into Influenza Therapeutics Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Influenza Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Global Influenza Therapeutics Market Size Share by Type (2014-2019)
  • Figure Global Influenza Therapeutics Market Size Market Share by Type (2014-2019)
  • Table Global Influenza Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Global Influenza Therapeutics Market Size Share by Application (2014-2019)
  • Figure Global Influenza Therapeutics Market Size Market Share by Application (2014-2019)
  • Figure Global Influenza Therapeutics Revenue Market Share by Application in 2018
  • Figure North America Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table North America Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table North America Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table North America Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table North America Influenza Therapeutics Market Share by Type 2014-2019
  • Table North America Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table North America Influenza Therapeutics Market Share by Application 2014-2019
  • Figure Europe Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table Europe Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Europe Influenza Therapeutics Market Share by Type 2014-2019
  • Table Europe Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Europe Influenza Therapeutics Market Share by Application 2014-2019
  • Figure China Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table China Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table China Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table China Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table China Influenza Therapeutics Market Share by Type 2014-2019
  • Table China Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table China Influenza Therapeutics Market Share by Application 2014-2019
  • Figure Japan Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table Japan Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Japan Influenza Therapeutics Market Share by Type 2014-2019
  • Table Japan Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Japan Influenza Therapeutics Market Share by Application 2014-2019
  • Figure Southeast Asia Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table Southeast Asia Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Southeast Asia Influenza Therapeutics Market Share by Type 2014-2019
  • Table Southeast Asia Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Southeast Asia Influenza Therapeutics Market Share by Application 2014-2019
  • Figure India Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table India Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table India Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table India Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table India Influenza Therapeutics Market Share by Type 2014-2019
  • Table India Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table India Influenza Therapeutics Market Share by Application 2014-2019
  • Figure Central & South America Influenza Therapeutics Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Influenza Therapeutics Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Influenza Therapeutics Market Share (2018-2019)
  • Table Central & South America Influenza Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Central & South America Influenza Therapeutics Market Share by Type 2014-2019
  • Table Central & South America Influenza Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Central & South America Influenza Therapeutics Market Share by Application 2014-2019
  • Table Abbott Laboratories Company Details
  • Table Abbott Laboratories Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Abbott Laboratories Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Abbott Laboratories Recent Development
  • Table Astrazeneca PLC Company Details
  • Table Astrazeneca PLC Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Astrazeneca PLC Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Astrazeneca PLC Recent Development
  • Table Biocryst Pharmaceuticals, Inc. Company Details
  • Table Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Biocryst Pharmaceuticals, Inc. Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Biocryst Pharmaceuticals, Inc. Recent Development
  • Table Chiron Corporation Company Details
  • Table Chiron Corporation Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Chiron Corporation Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Chiron Corporation Recent Development
  • Table CSL Limited Company Details
  • Table CSL Limited Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure CSL Limited Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table CSL Limited Recent Development
  • Table Daiichi Sankyo Co., Ltd. Company Details
  • Table Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Daiichi Sankyo Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Daiichi Sankyo Co., Ltd. Recent Development
  • Table Glaxosmithkline PLC Company Details
  • Table Glaxosmithkline PLC Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Glaxosmithkline PLC Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Glaxosmithkline PLC Recent Development
  • Table Mitsubishi Tanabe Pharma Corporation Company Details
  • Table Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Mitsubishi Tanabe Pharma Corporation Recent Development
  • Table Nanotherapeutics Inc. Company Details
  • Table Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Nanotherapeutics Inc. Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Nanotherapeutics Inc. Recent Development
  • Table Protein Sciences Corporation Company Details
  • Table Protein Sciences Corporation Revenue in Influenza Therapeutics Business 2014-2019 (Million US$)
  • Figure Protein Sciences Corporation Revenue Growth Rate in Influenza Therapeutics Business (2014-2019)
  • Table Protein Sciences Corporation Recent Development
  • Table Roche Holding AG Company Details
  • Table Sanofi SA Company Details
  • Table Shionogi & Co., Ltd. Company Details
  • Table Sinovac Biotech Ltd. Company Details
  • Table Global Influenza Therapeutics Market Size by Regions (Million US$) 2019-2025
  • Figure Global Influenza Therapeutics Market Size Share by Regions (2019-2025)
  • Figure Global Influenza Therapeutics Market Size Share by Regions in 2025
  • Figure North America Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure China Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure India Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Influenza Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Table Global Influenza Therapeutics Market Size by Product (2019-2025) (Million US$)
  • Figure Global Influenza Therapeutics Market Size by Product (2019-2025)
  • Figure Global Influenza Therapeutics Market Size by Product in 2025
  • Table Global Influenza Therapeutics Market Size by Application (2019-2025) (Million US$)
  • Figure Global Influenza Therapeutics Market Size by Application (2019-2025)
  • Figure Global Influenza Therapeutics Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top